Proposed Information Collection Activity; Comment Request, 48089-48090 [2017-22294]
Download as PDF
<![CDATA[
48089
Federal Register / Vol. 82, No. 198 / Monday, October 16, 2017 / Notices
or follow any new or changed items and
extant sections, which are topically
related. Researchers also conduct this
testing to identify redundant and
overlapping questions. Extant sections
of the questionnaire unrelated to new
items do not require testing. The
demographic questions on the core
Individuals who participate in fieldtesting are drawn from a different
sample than individuals who participate
in the BRFSS surveys. Participation is
voluntary and there is no cost to
participate. The average time burden per
response will be 22 minutes. The total
time burden across all respondents will
be approximately 241,518 hours.
BRFSS survey are included on each
field test.
CDC will submit change requests to
OMB annually to gain approval to
implement modifications identified in
field tests. Researchers typically
conduct field tests in a single state with
appropriate computer-assisted
telephone interview (CATI) capability.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
U.S. General Population ...................
Landline Screener ............................
Cell Phone Screener ........................
Field Test Screener ..........................
BRFSS Core Survey ........................
375,000
292,682
900
480,000
1
1
1
1
1/60
1/60
1/60
15/60
6,250
4,878
15
120,000
BRFSS Optional Modules ................
Field Test Survey .............................
440,000
500
1
1
15/60
45/60
110,000
375
...........................................................
........................
........................
........................
241,518
Annual Survey Respondents (Adults
>18 Years).
Field Test Respondents (Adults >18
Years).
Total ...........................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–22317 Filed 10–13–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–1083]
Agency Forms Undergoing Paperwork
Reduction Act Review—Evaluation of
the National Tobacco Prevention and
Control Public Education Campaign;
Correction
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice; correction.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) published
a document in the Federal Register of
October 3, 2017, concerning request for
comments on Agency Forms
Undergoing Paperwork Reduction Act
Review—Evaluation of the National
Tobacco Prevention and Control Public
Education Campaign. The document
provided the incorrect proposed project
type (Revision).
FOR FURTHER INFORMATION CONTACT:
Leroy Richardson, 1600 Clifton Road,
MS D–74, Atlanta, GA 30333; telephone
(404) 639–4965; email: omb@cdc.gov.
Correction
In the Federal Register of October 3,
2017, in FR Doc. 2017–21122, on page
46059, in the first column (Proposed
Project), correct the proposed project
type to read:
Evaluation of the National Tobacco
Prevention and Control Public Education
Campaign (OMB Control Number 0920–1083,
Expiration 09/30/2017)—Reinstatement with
Change—National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and
Prevention (CDC).
Dated: October 10, 2017.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–22256 Filed 10–13–17; 8:45 am]
BILLING CODE 4163–18–P
ethrower on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:59 Oct 13, 2017
Jkt 244001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Title: Community-Based Family
Resource and Support Grants (Name
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
changed to Child Abuse Prevention
Program—OIS notified 6/2007).
OMB No.: 0970–0155.
Description: The Program Instruction,
prepared in response to the enactment
of Community-Based Child Abuse
Prevention (CBCAP) program, as set
forth in Title II of the Child Abuse
Prevention and Treatment
Reauthorization Act of 2010 (Pub. L.
111–320) or CAPTA, provides direction
to the states and territories to
accomplish the purposes of (1)
supporting community-based efforts to
develop, operate, expand, and where
appropriate to network, initiatives
aimed at the prevention of child abuse
and neglect, and to support networks of
coordinated resources and activities to
better strengthen and support families to
reduce the likelihood of child abuse and
neglect, and; (2) fostering an
understanding, appreciation, and
knowledge of diverse populations in
order to be effective in preventing and
treating child abuse and neglect. This
Program Instruction contains
information collection requirements that
are found in CAPTA and pursuant to
receiving a grant award. The
information submitted will be used by
the agency to ensure compliance with
the statute, complete the calculation of
the grant award entitlement, and
provide training and technical
assistance to the grantee.
Respondents: State Governments.
E:\FR\FM\16OCN1.SGM
16OCN1
48090
Federal Register / Vol. 82, No. 198 / Monday, October 16, 2017 / Notices
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
Application .......................................................................................................
Annual Report ..................................................................................................
Estimated Total Annual Burden
Hours: 3,328.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research,
and Evaluation, 330 C Street SW.,
Washington, DC 20201, Attn: ACF
Reports Clearance Officer. Email
address: infocollection@acf.hhs.gov. All
requests should be identified by the title
of the information collection.
The Department specifically requests
comments on (a) whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Mary Jones,
ACF/OPRE Reports Clearance Officer.
[FR Doc. 2017–22294 Filed 10–13–17; 8:45 am]
ethrower on DSK3G9T082PROD with NOTICES
BILLING CODE 4184–29–P
52
52
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–D–0329]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Guidance for
Industry on Fees for Human Drug
Compounding Outsourcing Facilities
Under the Federal Food, Drug, and
Cosmetic Act
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
SUMMARY:
Fax written comments on the
collection of information by November
15, 2017.
DATES:
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, Fax: 202–
395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0776. Also
include the FDA docket number found
in brackets in the heading of this
document.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A63, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–5733, PRAStaff@
fda.hhs.gov.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
16:59 Oct 13, 2017
Jkt 244001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
Average
burden hours
per response
40
24
Total burden
hours
2,080
1,248
Guidance for Industry on Fees for
Human Drug Compounding
Outsourcing Facilities Under Sections
503B and 744K of the FD&C Act OMB
Control Number 0910–0776—Extension
This information collection supports
the Agency’s guidance on fees for
human drug compounding outsourcing
facilities under the Federal Food, Drug,
and Cosmetic Act (the FD&C Act). On
November 27, 2013, the President
signed the Drug Quality and Security
Act (DQSA) (Pub. L. 113–54) into law.
The DQSA added a new section, 503B
(21 U.S.C. 353B), to the FD&C Act,
creating a category of entities called
‘‘outsourcing facilities.’’ Outsourcing
facilities, as defined in section
503B(d)(4) of the FD&C Act, are
facilities that meet certain requirements
described in section 503B, including
registering with FDA as an outsourcing
facility and paying associated fees. Drug
products compounded in an
outsourcing facility can qualify for
exemptions from the FDA approval
requirements in section 505 of the FD&C
Act (21 U.S.C. 355), and the requirement
to label products with adequate
directions for use under section
502(f)(1) of the FD&C Act (21 U.S.C.
352(f)(1)), if the requirements in section
503B of the FD&C Act are met.
The guidance is intended for entities
that compound human drugs and elect
to register as outsourcing facilities
under section 503B of the FD&C Act.
Once an entity has elected to register as
an outsourcing facility, it must pay
certain fees to be registered as an
outsourcing facility. The guidance
describes the types and amounts of fees
that outsourcing facilities must pay, the
adjustments to fees required by law, the
way in which outsourcing facilities may
submit payment to FDA, the
consequences of outsourcing facilities’
failure to pay fees, and the way an
outsourcing facility may qualify as a
small business to obtain a reduction in
fees.
In the Federal Register of June 15,
2017 (82 FR 27493), we published a 60day notice requesting public comment
on the proposed extension of this
collection of information. No comments
were received. We therefore estimate the
burden associated with the information
collection as follows:
E:\FR\FM\16OCN1.SGM
16OCN1
]]>Agencies
[Federal Register Volume 82, Number 198 (Monday, October 16, 2017)]
[Notices]
[Pages 48089-48090]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-22294]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Comment Request
Title: Community-Based Family Resource and Support Grants (Name
changed to Child Abuse Prevention Program--OIS notified 6/2007).
OMB No.: 0970-0155.
Description: The Program Instruction, prepared in response to the
enactment of Community-Based Child Abuse Prevention (CBCAP) program, as
set forth in Title II of the Child Abuse Prevention and Treatment
Reauthorization Act of 2010 (Pub. L. 111-320) or CAPTA, provides
direction to the states and territories to accomplish the purposes of
(1) supporting community-based efforts to develop, operate, expand, and
where appropriate to network, initiatives aimed at the prevention of
child abuse and neglect, and to support networks of coordinated
resources and activities to better strengthen and support families to
reduce the likelihood of child abuse and neglect, and; (2) fostering an
understanding, appreciation, and knowledge of diverse populations in
order to be effective in preventing and treating child abuse and
neglect. This Program Instruction contains information collection
requirements that are found in CAPTA and pursuant to receiving a grant
award. The information submitted will be used by the agency to ensure
compliance with the statute, complete the calculation of the grant
award entitlement, and provide training and technical assistance to the
grantee.
Respondents: State Governments.
[[Page 48090]]
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Application..................................... 52 1 40 2,080
Annual Report................................... 52 1 24 1,248
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 3,328.
In compliance with the requirements of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Administration for Children and
Families is soliciting public comment on the specific aspects of the
information collection described above. Copies of the proposed
collection of information can be obtained and comments may be forwarded
by writing to the Administration for Children and Families, Office of
Planning, Research, and Evaluation, 330 C Street SW., Washington, DC
20201, Attn: ACF Reports Clearance Officer. Email address:
infocollection@acf.hhs.gov. All requests should be identified by the
title of the information collection.
The Department specifically requests comments on (a) whether the
proposed collection of information is necessary for the proper
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Mary Jones,
ACF/OPRE Reports Clearance Officer.
[FR Doc. 2017-22294 Filed 10-13-17; 8:45 am]
BILLING CODE 4184-29-P
